shutterstock_206660557

A study on centenarians links sphingotec’s biomarker bio-Adrenomedullin (bio-ADM) to longevity

Results of the CIAO (Cilento Intitiative on Aging Outcome) pilot study, presented today in the Italian town of Pollica, suggest that low blood levels of the peptide hormone Adrenomedullin (bio-ADM) are an indicator for such a good microcirculation. Making longevity measurable has long been a scientific goal as it could open up the avenue to a systematic identification of factors contributing to an extended life span. Read more…